 | Acorda Therapeutics Inc Shares Close in on 52-Week Low - Market Mover
nasdaq.com - January 16 at 3:58 AM |
 | Acorda Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
finance.yahoo.com - January 4 at 7:31 AM |
| Acorda Therapeutics Inc Shares Approach 52-Week Low - Market Mover
nasdaq.com - December 25 at 8:57 AM |
 | Worldwide Multiple Sclerosis Drugs Industry to 2027 - Featuring Abbvie, Acorda Therapeutics and Biogen Among Others - ResearchAndMarkets.com
benzinga.com - December 10 at 6:46 PM |
| Acorda Therapeutics Inc Shares Fall 3.9% Below Previous 52-Week Low - Market Mover
nasdaq.com - November 29 at 11:16 PM |
| Acorda Therapeutics Inc Shares Fall 5.0% Below Previous 52-Week Low - Market Mover
nasdaq.com - November 27 at 12:39 AM |
| Global Ataxia Treatment Market to Surpass US$ 47,360.7 Million by 2028, Says Coherent Market Insights (CMI)
ca.finance.yahoo.com - November 15 at 1:02 PM |
| Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Germany
nz.finance.yahoo.com - November 9 at 7:34 PM |
| Earnings Outlook For Acorda Therapeutics
benzinga.com - November 8 at 1:17 PM |
| Acorda Third Quarter 2021 Update: Webcast Scheduled for November 9, 2021
finance.yahoo.com - November 2 at 11:04 AM |
|
 | Post herpetic Neuralgia Treatment Market Growth Estimation, Geography Trends, Business Statistics, Developing Trends and Forecast 2026
marketwatch.com - October 28 at 11:02 PM |
| Dalfampridine Market Size, Segmented by Product Type, Applications, Distribution Channel, Growth, Trends, and Forecast 2027
marketwatch.com - October 26 at 2:23 PM |
 | Acorda Therapeutics: Managing The Transition
seekingalpha.com - October 4 at 4:59 PM |
| Post Herpetic Neuralgia Therapies Market Research Report Includes Size, Capacity, Production, Revenue, Gross Margin, Forecast to 2027
marketwatch.com - September 14 at 3:18 AM |
| Acorda Therapeutics To Reduce Headcount; Names Lauren Sabella COO - Quick Facts
nasdaq.com - September 9 at 12:18 PM |
| Acorda Therapeutics Announces Corporate Restructuring, Management Changes
finance.yahoo.com - September 9 at 12:18 PM |
| Return on Capital Employed Insights for Acorda Therapeutics
benzinga.com - August 27 at 11:10 PM |
| Acorda Therapeutics Reports Second Quarter 2021 Financial Results
finance.yahoo.com - August 5 at 7:31 PM |
 | Here's what to expect from Acorda Therapeutics's earnings report
markets.businessinsider.com - August 3 at 7:39 PM |
| Acorda Second Quarter 2021 Update: Webcast/Conference Call Scheduled for August 5, 2021
finance.yahoo.com - July 30 at 5:46 PM |
| Will Acorda Therapeutics (ACOR) Report Negative Q2 Earnings? What You Should Know
finance.yahoo.com - July 27 at 7:43 PM |
| Acorda Therapeutics Continues To Maneuver For A Turnaround
seekingalpha.com - July 24 at 1:57 AM |
| Acorda Therapeutics Shares Up Friday After Deal to Commercialize Inbrija in Spain
marketwatch.com - July 23 at 5:49 PM |
 | Acorda Flies on new Supply Deal
baystreet.ca - July 23 at 12:44 PM |
| Acorda Therapeutics in Deal to Commercialize Inbrija in Spain
marketwatch.com - July 22 at 8:22 PM |
| Acorda Therapeutics Shares up After Deal to Commercialize Inbrija in Spain
marketwatch.com - July 22 at 8:22 PM |
| Acorda Therapeutics Announces Agreement to Commercialize INBRIJA® in Spain
finance.yahoo.com - July 22 at 8:22 PM |
| Acorda Therapeutics, Inc. Common Stock (ACOR)
nasdaq.com - July 13 at 12:56 AM |
| Insights on the Spinal Cord Trauma Treatment Global Market to 2027 - Featuring Acorda Therapeutics, BioTime and Pfizer Among Others
benzinga.com - June 21 at 1:23 PM |
| Hedge Funds Are Buying Acorda Therapeutics Inc (ACOR) Again
finance.yahoo.com - June 19 at 12:50 AM |
| Acorda Therapeutics Announces Repayment of Convertible Senior Notes
finance.yahoo.com - June 16 at 9:29 AM |
| Acorda Therapeutics, Inc. 2021 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 7 at 11:27 AM |
|
 | BRIEF-Acorda Therapeutics Reports First Quarter 2021 Financial Results
msn.com - May 6 at 5:34 PM |
| Acorda Therapeutics Reports First Quarter 2021 Financial Results
finance.yahoo.com - May 6 at 5:34 PM |
| Acorda Therapeutics: Buying Before The Coast Is Clear
seekingalpha.com - April 29 at 9:19 PM |
| Acorda Therapeutics First Quarter 2021 Update: Webcast/Conference Call Scheduled for May 6, 2021
finance.yahoo.com - April 29 at 6:48 PM |
| All You Need to Know About Acorda (ACOR) Rating Upgrade to Strong Buy
finance.yahoo.com - April 27 at 5:31 PM |
| Spinal Cord Injury Clinical Trials Review: A Multitude of Emerging Drugs for Better Treatment
benzinga.com - April 21 at 10:41 PM |
| J&J (JNJ) Q1 Earnings Top, COVID-19 Vaccine Brings $100M Sales
finance.yahoo.com - April 20 at 3:23 PM |
| Using the Action in Acorda Therapeutics $ACOR to our Advantage
marketwatch.com - March 16 at 9:44 AM |
| Vertex (VRTX) Type I Diabetes Candidate Clinical Study Begins
finance.yahoo.com - March 11 at 12:17 PM |
| Has Acorda Therapeutics (ACOR) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - March 10 at 1:34 PM |
| The Acorda Therapeutics, Inc. (NASDAQ:ACOR) Analyst Just Boosted Their Forecasts By A Dazzling Amount
finance.yahoo.com - March 9 at 8:19 AM |
| Acorda Therapeutics to Present at H.C. Wainwright Global Life Sciences Virtual Conference
finance.yahoo.com - March 8 at 7:44 PM |
| QIAGEN (QGEN) Unveils Digital Platform for Syndromic Testing
finance.yahoo.com - March 5 at 6:04 PM |
| Acorda Therapeutics, Inc. 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 5 at 2:16 PM |
| 11 Stocks Moving In Thursday's After-Hours Session
msn.com - March 4 at 8:51 PM |
| Acorda: Q4 Earnings Snapshot
finance.yahoo.com - March 4 at 8:51 PM |
| Acorda Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
finance.yahoo.com - March 4 at 8:51 PM |
| Acorda Therapeutics is about to announce earnings — here's what Wall Street expects
markets.businessinsider.com - March 2 at 1:31 PM |
